Latest News

If you have been eyeing Tenaris or already have it in your portfolio, you are probably wondering if now is the moment to make your move or take a breather. With the stock closing at $15.47 recently and showing some upbeat momentum in the past week, up 1.9%, plus a solid 3.4% return over the last month, it is no surprise that investors are talking. Despite some volatility so far this year, as the share price is down 16.1% year-to-date, Tenaris has rewarded long-term holders handsomely,...

Trying to figure out what to do with Saipem stock? You are not alone. Whether you are a new investor or someone tracking your positions closely, there is plenty to unpack behind this company’s recent moves. In just the past month, Saipem shares have climbed 10.2%, adding to a huge 32.6% surge over the past year. Even after some bumps earlier this year, and a five-year performance still showing a loss of 30.8%, the stock has more than tripled (up 272.4%) in the last three years. Those kinds of...

Thinking about what to do next with Brookdale Senior Living stock? You are definitely not alone. Investors have watched this name closely, and its recent movements may have complicated your decision a bit. The stock closed at $8.06, taking a small dip of -3.4% over the past week. But step back and you will see some remarkable momentum: up 4.8% for the month, and a whopping 59.3% so far this year. That adds to a powerful longer-term trend. Brookdale shares have climbed nearly 188% over the...

Yunfeng Financial Group (SEHK:376) has just been added to the S&P Global BMI Index, an event that often attracts the attention of investors and index funds. Index inclusions like this can generate new trading interest and increase liquidity. See our latest analysis for Yunfeng Financial Group. Shares have gained momentum following the S&P Global BMI Index inclusion, with a recent share price return of 5.1% year-to-date and a steady 3.7% total shareholder return over the past year, which hints...

MISUMI Group (TSE:9962) has just completed its previously announced share buyback, repurchasing over 3 million shares or 1.11% of its outstanding stock between July and September 2025. This completes a significant capital allocation decision for the company. See our latest analysis for MISUMI Group. MISUMI Group’s recent buyback comes as the stock has mostly traded sideways over the past year, with a 1-year total shareholder return of -0.09% and only mild movement in the share price. That...

As the Australian market experiences a slight pullback following a bullish surge, investors are keenly observing the ASX 200's movements amidst fluctuating global economic factors such as U.S. government shutdown concerns and rising gold prices. In this context, identifying undervalued stocks can be particularly appealing, as they may offer potential opportunities for growth in a market that is currently experiencing volatility and consolidation.

Trying to decide what to do with Chemed stock right now? You are not alone. Shareholders and would-be investors alike have been watching the company’s journey with a mix of curiosity and concern. After all, Chemed’s story over the past year has not followed a gentle upward climb. Instead, it has seen some notable slides, including a 16.0% drop year-to-date and an even steeper 23.4% decline over the past 12 months. Even stretching out to five years, Chemed’s shares are down 5.9%, which can...

Thinking about your next move with American Homes 4 Rent? You are not alone. The real estate sector has kept investors guessing lately, and American Homes 4 Rent has seen its fair share of ups and downs. Over the past week, the stock held steady with a slight 0.1% bump, but the 30-day drop of 6.3% and a year-to-date slide of 11.2% might be giving some pause. Long-term holders have still netted a gain, with more than 22% over five years, but recent dips have many wondering whether there is...

Peninsula Energy (ASX:PEN) is seeing renewed attention after a packed stretch of developments, including fresh share and options issues, director share buys, changes in major investors, and a recent auditor flag on its financial footing. See our latest analysis for Peninsula Energy. All these moves and the auditor’s recent caution have Peninsula Energy firmly in the spotlight, but the stock’s longer-term trends paint a nuanced picture. Momentum lately has been modest, with a 1-month share...

In recent weeks, ProAssurance received a consensus "Hold" recommendation from six ratings firms, while Zacks Research raised its rating to "strong-buy" and institutional investors and hedge funds significantly increased their shareholdings. This combination of analyst upgrade and heightened institutional interest signals a shift in market sentiment and renewed confidence in the company’s outlook. We’ll examine how the increased institutional ownership may impact ProAssurance’s investment...

Thinking about making a move with Pinnacle West Capital? You are not alone. The stock has caught more attention lately, pushing up 3.9% over the past week and up 1.3% in the last month. Year to date, Pinnacle West Capital is sitting at a 7.0% gain and is up 6.7% over the past year. If you have been holding on for a while, the ride has been even better, with a substantial 68.9% return across three years and 36.3% over five years. What is driving this? Many investors are attributing the recent...

If you have been eyeing Slide Insurance Holdings or already hold some shares, you are probably wondering whether now is a smart time to buy, sell, or simply sit tight. The stock has certainly been on the move, with prices rising 5.2% over the past week and up 14.8% in the last month. That momentum stands in stark contrast to its year-to-date performance, where shares are still down 22.3%. This kind of turnaround often hints at shifting investor sentiment, possibly tied to developments in the...

Wondering whether Victory Capital Holdings is a buy, a sell, or a hold after another roller-coaster month? You are not alone. For anyone tracking the stock’s moves, the past year has been quite the ride: up 16.8% over twelve months, climbing a remarkable 308.8% over five years, but giving back some ground with an 8.5% dip in the past 30 days. Just last week, shares edged down by 0.5%, reflecting shifting market sentiment rather than any headline-shaking news. With momentum this strong over...

LENZ Therapeutics (LENZ) has just announced that VIZZ, its newly FDA-approved aceclidine-based eye drop for presbyopia, is now being distributed to eye care professionals across the United States. Consumer availability is set for October, and retail expansion will follow soon. See our latest analysis for LENZ Therapeutics. With VIZZ now hitting the market, LENZ Therapeutics is in the spotlight, and the recent commercial launch has stirred up investor interest. Over the past year, the total...

Thinking about what to do with Fincantieri stock? You are not alone. With price moves that leave most stocks in the dust, it is no wonder investors are curious. Over the past week, Fincantieri’s shares have jumped 22.5%. Stretch that timeline to a year and the return stands at a whopping 453%. Even the most patient, long-term holders have seen gains of 612% over three years and nearly 500% over the last five. Most recently, the company has benefited from broader optimism in European...

Thinking about what to do with Informatica stock? You are not alone. Recent movement in the shares has caught a lot of attention, and there is no shortage of opinions out there. Right now, the stock is hovering near $24.92, and you might notice the numbers are a bit of a mixed bag. Over the past week and month, Informatica has inched up by 0.4% and 0.6% respectively, but if you look at the year-to-date performance, it is down 2.1%. The past year also shows a slight dip, with shares falling...

AngioDynamics (ANGO) caught the market’s attention after reporting first quarter financial results that exceeded expectations. Revenue growth was powered by its Med Tech business, and the company upgraded its outlook for the rest of the year. See our latest analysis for AngioDynamics. After surprising the market with quarterly sales growth and an outlook upgrade, AngioDynamics has captured renewed investor interest. The momentum from its Med Tech strength coincides with a steady recovery, as...

ClearPoint Neuro recently announced the appointment of Dr. Paul Larson as Chief Medical Officer, the unveiling of its proprietary Robotic Neuro-Navigation System for minimally invasive cranial procedures, and new insider buying from directors. The Robotic Neuro-Navigation System aims to provide greater consistency for cell and gene therapy delivery, and ClearPoint's drug delivery technology was spotlighted in strong Huntington's disease trial results from a biopharma collaborator. Let's...

If you have been watching Legrand lately and wondering whether now is the right time to jump in or take your profits, you are definitely not alone. The stock has been a standout performer, and just glancing at its numbers, it is hard not to be impressed. With a return of 52.5% since the start of the year and a one-year climb of 43.8%, Legrand has not only defied cautious sentiment but managed to outpace the broader market. Even over the last three years, the stock has soared an impressive...

Bravura Solutions (ASX:BVS) shares are drawing fresh interest after the company raised its annual revenue and profit outlook and named a new CEO. These moves suggest shifting momentum and evolving leadership. See our latest analysis for Bravura Solutions. Bravura’s latest leadership shake-up and raised guidance have prompted the shares to touch fresh 12-month highs, supported by a stronger British pound and improved project revenue in EMEA. While the one-year total shareholder return is just...

Reitar Logtech Holdings recently announced the formal signing of a Strategic Cooperation Memorandum of Understanding with AI logistics company NEXX to jointly invest in a Smart Fulfillment Center project in Doha, Qatar, as part of broad plans for logistics automation in the region. This initiative not only launches a large-scale, AI-driven logistics facility but also aligns with Qatar's 2030 National Vision and the digital corridor ambitions of China's Belt and Road Initiative. We'll explore...

Thinking about what to do with VNET Group stock? You are definitely not alone. It has been a roller coaster for shareholders, with the price jumping a whopping 33.9% in the last month and up an eye-popping 109.1% since the start of the year. If you have been holding on for the long-term, you have enjoyed a 151.3% return over the past year, but maybe you are also feeling the sting from further back when the stock was down 54.1% over five years. Those big swings have a way of making every...

Algoma Steel Group (NasdaqGM:ASTL) has drawn renewed attention after announcing a strategic collaboration with TransPod and Supreme Steel on a sustainable, high-speed infrastructure project in Canada. This move highlights Algoma's ongoing business transformation and its role within the industry. See our latest analysis for Algoma Steel Group. Recent months have brought a steady flow of news for Algoma Steel Group. The company has secured substantial government-backed loan facilities,...

3612 (TSE:3612) reported a net profit margin of 4.7%, up from 3.8% a year earlier, with earnings soaring 41.3% year-over-year. The company’s five-year average annual earnings growth is an impressive 72.8%, and looking ahead, management guides for earnings and revenue to rise 13.6% and 8.9% per year, both clearly outpacing broader Japanese market expectations. With profitability on the rise, high-quality earnings, and its valuation well below peers, the latest results paint a picture of...